JPRN-UMIN000010185
Completed
未知
In DIAlysis patient study of efficacy and safety of MONthly minoDoronate - DIAMOND study
Oita university facility of medicine0 sites50 target enrollmentMarch 10, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Oita university facility of medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients who have obstacles which delays esophagus passage of stricture of the esophagus or achalasia 2\)Patients who have raised the upper part of the body for 30 minutes or it cannot be standing 3\)hypersensitivity for bisphosphonate 4\)The patient with hypocalcemia 5\)Patients in or expecting pregnancy 6\)Patients who diagnosed malignancy 7\)Patients receiving specific treatments that affect bone and mineral metabolism such as recombinant human PTH, and Eldecalcitol 8\)Patients who took SERM within a month before this trial 9\)Patients who took bisphophonate within 6 month before this trial 10\)Patients who are inappropriate for this study by physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The effects of irbesartan and nebivolol on ambulatory blood pressure in patients with intradialytic hypertension.Patients with end-stage renal disease on hemodialysis with intradialytic hypertensionUrological and Genital DiseasesEnd-stage renal diseaseISRCTN13587185Aristotle University of Thessaloniki School of Medicine38
Active, not recruiting
Phase 1
Estudio con pacientes en prediálisis y diálisis renal para evaluar la seguridad, tolerabilidad e inmunogenicidad de la vacuna recombinante contra la hepatitis B fabricada mediante un proceso modificado A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured with a Modified Process - Estudio en diálisis de la vacuna de la Hepatitis B (recombinante)EUCTR2006-003650-20-ESMerck Sharp & Dohme de España, S.A.276
Completed
Not Applicable
Investigation of the clinical effect of hemodialysis using electrolyzed waterrenal failure requiring hemodialysis (HD)JPRN-UMIN000025113ephrology, Osaka National Hospital, NHO40
Completed
Not Applicable
Exploratory clinical trial of dialysis dose monitor with optical measurementEnd stage renal diseaseJPRN-UMIN000011082Tokyo Women's Medical University Department of Blood Purification30
Recruiting
Phase 1
A pilot study for chronic dialysis patients: Safety study using CV port and new needle for blood return of chronic dialysis patientsJPRN-jRCTs032200024Yamagata Kunihiro5